Asia Pacific Continuous Glucose Monitoring Systems Market is expected to grow at a CAGR of 32% during 2016 -2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report,  Asia Pacific Continuous Glucose Monitoring Systems (CGMS) Market , published by KBV Research, the Asia Pacific Continuous Glucose Monitoring Systems Market is expected togrow at a CAGR of 32% during 2016 -2022.

The Sensors market dominated the Asia Pacific Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 33.3% during the forecast period. The ICUs market followed the Diagnostic centers/clinics market in the Asia Pacific Continuous Glucose Monitoring Systems Market in 2015. However, Home Healthcare market is expected to grow at CAGR of 44.5% during 2016-2022.contributed the larger revenue share to the Asia Pacific Continuous Glucose Monitoring Systems Market in 2015, and is expected to grow at a CAGR of 33.3% during the forecast period.

The China market registered the largest revenue share in the Asia Pacific Continuous Glucose Monitoring Systems Sensors Market in 2015. However, India market is expected to grow at CAGR of 35.6% during 2016-2022.

The report highlights the adoption of Continuous Glucose Monitoring Systems in Asia Pacific.Based on the Component, the Asia Pacific Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: https://www.kbvresearch.com/global-continuous-glucose-monitoring-systems-market/

Research Scope

The market is segmented based on Component, End User and Country.

Asia Pacific Continuous Glucose Monitoring Systems Market, by Component

  • Hardware
  • Software
  • Services

Asia Pacific Continuous Glucose Monitoring Systems Market, by End User

  • Displays Terminals
  • Interface Software
  • Industrial PCs
  • Other Controllers

Asia Pacific Continuous Glucose Monitoring Systems Market, by Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Company Profiles

  • Roche Diagnostics
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk
  • Ypsomed AG
  • GlySens Incorporated
  • Medtronic Plc and
  • Johnson & Johnson

Related Reports-

Europe Continuous Glucose Monitoring Systems Market

North America Continuous Glucose Monitoring Systems Market

Global Continuous Glucose Monitoring Systems Market

Lamea Continuous Glucose Monitoring Systems Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.